TSE:MFC

Manulife Financial (MFC.TO)

60.67
+0.26 (0.43%)
as of Jul 22, 2026, 8:00:00 pm Market Open.
1632 watching
0
Investor Insights
star iconJul 22, 2026, 12:00 am

This summary was created by AI, based on 27 opinions in the last 12 months.

Manulife Financial (MFC) has garnered a mostly positive outlook among various experts, highlighting its competitive positioning within the Canadian financial sector, particularly in comparison to major banks like TD and SLF. Analysts note MFC's ongoing strength in wealth management and healthy growth prospects in Asia, although there are concerns regarding its current valuation, as it trades over 2x book value and exhibits only moderate earnings growth. Despite being classified as slightly overbought, its charts remain healthy, with many recommending caution yet seeing potential for growth in the long run. The company's strong dividend yield and management strategies, particularly in alternative investments, also contribute to a favorable long-term investment story, although short-term volatility may present opportunities for those willing to enter at lower price points.

consensus icon
Consensus
Positive
valuation icon
Valuation
Fair Value
review icon
Similar
SLF,SLF
BUY
Prefers this company over other Canadian insurance companies.
DON'T BUY
Overvalued in relation to their growth. 2- X earnings. PK for long term.
DON'T BUY
Expensive. Prefers US companies. Could go to $50/51.
TOP PICK
Highest ROE (return on equity) of insurance companies. Good growth expected through their international interests.
DON'T BUY
This company would be an acquirer, so prefers Canada Life and Clarica.
DON'T BUY
Not for the near term.
BUY
A great play on the financial sector. Their Asian market should do well. Well managed. A core holding.
BUY
Good long term holding.
BUY
Insurance companies are solid, stable and have good dividends.
BUY
Efficient. Well managed.
PAST TOP PICK
(Was a top pick on Apr 11 up 1%) Still likes
BUY
Still has upside in the long term, but not in the short term.
STRONG BUY
Excellent company. Good price.
TOP PICK
Will grow its earnings at 45% over the next few years. Good Asian growth. Good valuation.
BUY
Excellent company. Has come down.
Showing 2,176 to 2,190 of 2,283 entries